Aluminum Adjuvant Improves Survival Via NLRP3 Inflammasome and Myeloid Non-Granulocytic Cells in a Murine Model of Neonatal Sepsis. Issue 2 (February 2021)
- Record Type:
- Journal Article
- Title:
- Aluminum Adjuvant Improves Survival Via NLRP3 Inflammasome and Myeloid Non-Granulocytic Cells in a Murine Model of Neonatal Sepsis. Issue 2 (February 2021)
- Main Title:
- Aluminum Adjuvant Improves Survival Via NLRP3 Inflammasome and Myeloid Non-Granulocytic Cells in a Murine Model of Neonatal Sepsis
- Authors:
- Rincon, Jaimar C.
Hawkins, Russell B.
Hollen, Mckenzie
Nacionales, Dina C.
Ungaro, Ricardo
Efron, Philip A.
Moldawer, Lyle L.
Larson, Shawn D. - Abstract:
- Abstract : ABSTRACT: Neonatal sepsis leads to significant morbidity and mortality with the highest risk of death occurring in preterm (<37 weeks) and low birth weight (<2, 500 g) infants. The neonatal immune system is developmentally immature with well-described defects in innate and adaptive immune responses. Immune adjuvants used to enhance the vaccine response have emerged as potential therapeutic options, stimulating non-specific immunity and preventing sepsis mortality. Aluminum salts ("alum") have been used as immune adjuvants for over a century, but their mechanism of action remains poorly understood. This study aims to identify potential mechanisms by which pretreatment with alum induces host protective immunity to polymicrobial sepsis in neonatal mice. Utilizing genetic and cell-depletion studies, we demonstrate here that the prophylactic administration of aluminum adjuvants in neonatal mice improves sepsis survival via activation of the nucleotide oligomerization domain-like receptor family, pyrin-domain-containing 3 inflammasome and dendritic cell activation. Furthermore, this beneficial effect is dependent on myeloid, non-granulocytic Gr1-positive cells, and MyD88-signaling pathway activation. These findings suggest a promising therapeutic role for aluminum-based vaccine adjuvants to prevent development of neonatal sepsis and improve mortality in this highly vulnerable population. Abstract : Supplemental Digital Content is available in the text
- Is Part Of:
- Shock. Volume 55:Issue 2(2021)
- Journal:
- Shock
- Issue:
- Volume 55:Issue 2(2021)
- Issue Display:
- Volume 55, Issue 2 (2021)
- Year:
- 2021
- Volume:
- 55
- Issue:
- 2
- Issue Sort Value:
- 2021-0055-0002-0000
- Page Start:
- Page End:
- Publication Date:
- 2021-02
- Subjects:
- Adjuvant -- alum -- dendritic cells -- neonatal sepsis -- NLRP3 inflammasome
Shock -- Periodicals
Shock -- Periodicals
Choc (Pathologie) -- Périodiques
Shock
Periodicals
616.0475 - Journal URLs:
- http://www.shockjournal.com ↗
http://ovidsp.ovid.com/ovidweb.cgi?T=JS&NEWS=n&CSC=Y&PAGE=toc&D=yrovft&AN=00024382-000000000-00000 ↗
http://journals.lww.com ↗ - DOI:
- 10.1097/SHK.0000000000001623 ↗
- Languages:
- English
- ISSNs:
- 1073-2322
- Deposit Type:
- Legaldeposit
- View Content:
- Available online (eLD content is only available in our Reading Rooms) ↗
- Physical Locations:
- British Library DSC - 8267.443000
British Library DSC - BLDSS-3PM
British Library HMNTS - ELD Digital store - Ingest File:
- 21918.xml